Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/128513
- Title:
- Effect of Raloxifene on Periapical Lesions in Ovariectomized Rats
- Universidade Estadual Paulista (UNESP)
- 0099-2399
- Introduction: The aim of this study was to evaluate the effect of raloxifene (RLX) during progression of periapical lesions in ovariectomized (OVX) rats. Methods: Female Wistar rats were OVX or subjected to sham surgery and received vehicle or MX by gavage for 90 days. The treatment groups were as follows: sham surgery and treated with vehicle (SHAM-veh), OVX and treated with vehicle (OVX-veh), and OVX and treated with RLX (OVX-RLX). During treatment, the pulp of lower first molar was exposed to the oral. environment for induction of periapical lesion that was analyzed 7 or 30 days aftdr procedure. Blood samples were taken from jugular vein for measurement of estradiol, and the mandibles were removed and prepared for radiographic, histopathologic, histometric, and immunohistochemical analysis. Results: Estradiol plasma concentration showed hypoestrogenism in OVX rats. The histopathologic analysis of the OVX/RLX group was similar to that of the SHAM-veh group, whereas OVX-veh group showed larger penapical lesions with more intense inflammatory response and more cells positive for tartrate-resistant acid phosphatase. Radiographically, the groups were similar, but lesions on day 7 were smaller than lesions on day 30. Conclusions: The results suggest that hypoestrogenism potentiates the progression of periapical lesions, and such condition was reversed by treatment with RLX.
- 1-May-2015
- Journal Of Endodontics. New York: Elsevier Science Inc, v. 41, n. 5, p. 671-675, 2015.
- 671-675
- Elsevier B.V.
- Bone metabolism
- estrogen
- ovariectomized
- periapical lesion
- raloxifene
- http://www.sciencedirect.com/science/article/pii/S0099239914011431
- Acesso restrito
- outro
- http://repositorio.unesp.br/handle/11449/128513
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.